Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation.

Gallego I, Marceñido B, Ciriza J, Galindo S, López-Paniagua M, de la Mata A, Puras G, Calonge M, Pedraz JL, Nieto-Miguel T

Open source

DOI: 10.1016/j.jconrel.2026.115305
Published: 2026 Aug 25
Container: Journal of controlled release : official journal of the Controlled Release Society
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115305,
  title = {Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation.},
  author = {Gallego I and Marceñido B and Ciriza J and Galindo S and López-Paniagua M and de la Mata A and Puras G and Calonge M and Pedraz JL and Nieto-Miguel T},
  year = {2026},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  doi = {10.1016/j.jconrel.2026.115305},
  url = {https://doi.org/10.1016/j.jconrel.2026.115305}
}

RIS

TY  - JOUR
TI  - Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation.
AU  - Gallego I
AU  - Marceñido B
AU  - Ciriza J
AU  - Galindo S
AU  - López-Paniagua M
AU  - de la Mata A
AU  - Puras G
AU  - Calonge M
AU  - Pedraz JL
AU  - Nieto-Miguel T
PY  - 2026
JO  - Journal of controlled release : official journal of the Controlled Release Society
DO  - 10.1016/j.jconrel.2026.115305
UR  - https://doi.org/10.1016/j.jconrel.2026.115305
ER  -

APA

I, G., B, M., J, C., S, G., M, L., A, D. L. M., G, P., M, C., JL, P., & T, N. (2026). Nano-engineered mesenchymal stem cells as a platform for targeted and biologically regulated drug delivery in ocular surface inflammation.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115305

Source records

pubmed · retrieved 2026-09-25T08:42:54.280Z